Full Product Details
Author: Wei Zhao ,
Harry Yang
Publisher: Taylor & Francis Inc
Imprint: Chapman & Hall/CRC
Volume: 69
Dimensions:
Width: 15.60cm
, Height: 1.80cm
, Length: 23.40cm
Weight: 0.470kg
ISBN: 9781482216745
ISBN 10: 1482216744
Pages: 240
Publication Date: 19 December 2014
Audience:
College/higher education
,
Professional and scholarly
,
Postgraduate, Research & Scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Reviews
This book is a welcome addition to the literature and fills a needed niche since last book written on drug synergism was over 15 years ago . . . each chapter presents a different technique for solving common challenges in the development of drug combinations. . . Overall, this book serves as a good reference for both researchers in the field of statistics and drug combination development. ~ Jessica L. Jaynes, California State University, Fullerton Investigating drug combinations is a steadily growing area in preclinical and clinical research.As usual, specific statistical methodology is needed to handle these kinds of trials. . . .the book is generallywell structured and the majority of sections actually builds up on and refers to each other. This book provides a good overview on and a good introduction to the topic of statistical methods for drug combination studies, especially regarding the preclinical part. ~ Tim Holland-Letz, German Cancer Research Center Heidelberg
This book is a welcome addition to the literature and fills a needed niche since last book written on drug synergism was over 15 years ago . . . Overall, this book serves as a good reference for both researchers in the field of statistics and drug combination development. ~ Jessica L. Jaynes, California State University, Fullerton Investigating drug combinations is a steadily growing area in preclinical and clinical research.As usual, specific statistical methodology is needed to handle these kinds of trials. . . .the book is generallywell structured and the majority of sections actually builds up on and refers to each other. This book provides a good overview on and a good introduction to the topic of statistical methods for drug combination studies, especially regarding the preclinical part. ~ Tim Holland-Letz, German Cancer Research Center Heidelberg This book is a welcome addition to the literature and fills a needed niche since last book written on drug synergism was over 15 years ago . . . each chapter presents a different technique for solving common challenges in the development of drug combinations. . . Overall, this book serves as a good reference for both researchers in the field of statistics and drug combination development. ~ Jessica L. Jaynes, California State University, Fullerton Investigating drug combinations is a steadily growing area in preclinical and clinical research.As usual, specific statistical methodology is needed to handle these kinds of trials. . . .the book is generallywell structured and the majority of sections actually builds up on and refers to each other. This book provides a good overview on and a good introduction to the topic of statistical methods for drug combination studies, especially regarding the preclinical part. ~ Tim Holland-Letz, German Cancer Research Center Heidelberg
This book is a welcome addition to the literature and fills a needed niche since last book written on drug synergism was over 15 years ago ... each chapter presents a different technique for solving common challenges in the development of drug combinations... Overall, this book serves as a good reference for both researchers in the field of statistics and drug combination development. ~ Jessica L. Jaynes, California State University, Fullerton
